Novo Nordisk: Keep It Low So I Can Keep Accumulating (Rating Upgrade) (NYSE:NVO)

Novo Nordisk's Q2 growth, strong market share, and innovative drug pipeline make it a top stock pick. Click here to find out why NVO stock is a Strong Buy.